The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Open accessAbstract
The Wnt/β-catenin pathway, which signals through the Frizzled (Fzd) receptor family and several coreceptors, has long been implicated in cancer. Here we demonstrate a therapeutic approach to targeting the Wnt pathway with a monoclonal antibody, OMP-18R5. This antibody, initially identified by binding to Frizzled 7, interacts with five Fzd receptors through a conserved epitope within the extracellular domain and blocks canonical Wnt signaling induced by multiple Wnt family members. In xenograft studies with minimally passaged human tumors, this antibody inhibits the growth of a range of tumor types, reduces tumor-initiating cell frequency, and exhibits synergistic activity with standard-of-care chemotherapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In CRC cells, Wnt pathway inhibition has been demonstrated to inhibit cell proliferation, reduce tumor-initiating cell numbers, and impair tumor growth in CRC xenograft models [190,191,192,193].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [191]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Phenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
Self-citationTankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Nusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
Towards an integrated view of Wnt signaling in development
van Amerongen, R., & Nusse, R. (2009) · Development · doi:10.1242/dev.033910 · Cited by 1,175
Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., & Polakis, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.3046 · Cited by 1,021
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 992
The many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866
Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., & Polakis, P. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70226-x · Cited by 836
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Fodde, R., & Brabletz, T. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.007 · Cited by 785
Wnt and calcium signaling: β-Catenin-independent pathways
Kohn, A. D., & Moon, R. T. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.022 · Cited by 730
Self-Renewal and Cancer of the Gut: Two Sides of a Coin
Radtke, F., & Clevers, H. (2005) · Science · doi:10.1126/science.1104815 · Cited by 690
Wright, M. H., Calcagno, A. M., Salcido, C. D., Carlson, M. D., Ambudkar, S. V., & Varticovski, L. (2008) · Breast Cancer Research · doi:10.1186/bcr1855 · Cited by 642
Kuhnert, F., Davis, C. R., Wang, H.-T., Chu, P., Lee, M., Yuan, J., Nusse, R., & Kuo, C. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536800100 · Cited by 636
Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
Malanchi, I., Peinado, H., Kassen, D., Hussenet, T., Metzger, D., Chambon, P., Huber, M., Hohl, D., Cano, A., Birchmeier, W., et al. (2008) · Nature · doi:10.1038/nature06835 · Cited by 597
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002428 · Cited by 589
Self-citationApc Tumor Suppressor Gene Is the “Zonation-Keeper” of Mouse Liver
Benhamouche, S., Decaens, T., Godard, C., Chambrey, R., Rickman, D. S., Moinard, C., Vasseur-Cognet, M., Kuo, C. J., Kahn, A., Perret, C., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.015 · Cited by 543
Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains
Dann, C. E., Hsieh, J.-C., Rattner, A., Sharma, D., Nathans, J., & Leahy, D. J. (2001) · Nature · doi:10.1038/35083601 · Cited by 473
DiMeo, T. A., Anderson, K., Phadke, P., Feng, C., Perou, C. M., Naber, S., & Kuperwasser, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4135 · Cited by 414
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Hoey, T., Yen, W.-C., Axelrod, F., Basi, J., Donigian, L., Dylla, S., Fitch-Bruhns, M., Lazetic, S., Park, I.-K., Sato, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.019 · Cited by 398
Self-citationLu, D., Choi, M. Y., Yu, J., Castro, J. E., Kipps, T. J., & Carson, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110431108 · Cited by 395
A Wnt Survival Guide: From Flies to Human Disease
Chien, A. J., Conrad, W. H., & Moon, R. T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.445 · Cited by 376
Yan, D., Wiesmann, M., Rohan, M., Chan, V., Jefferson, A. B., Guo, L., Sakamoto, D., Caothien, R. H., Fuller, J. H., Reinhard, C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261574498 · Cited by 366
Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer
Mazieres, J., He, B., You, L., Xu, Z., Lee, A. Y., Mikami, I., Reguart, N., Rosell, R., McCormick, F., & Jablons, D. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1389 · Cited by 271
Rothe, C., Urlinger, S., Löhning, C., Prassler, J., Stark, Y., Jäger, U., Hubner, B., Bardroff, M., Pradel, I., Boss, M., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.12.018 · Cited by 247
Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy
Wang, Y. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0282 · Cited by 216
The regulation and role of osteopontin in malignant transformation and cancer
ELTANANI, M., CAMPBELL, F., KURISETTY, V, JIN, D., MCCANN, M., & RUDLAND, P. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.010 · Cited by 174
The Soluble Wnt Receptor Frizzled8CRD-hFc Inhibits the Growth of Teratocarcinomas In vivo
DeAlmeida, V. I., Li, M., Ernst, J. A., Koeppen, H., Polakis, P. G., & Rubinfeld, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0266 · Cited by 139
Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular Carcinoma
Hu, J., Dong, A., Fernández-Ruiz, V., Shan, J., Kawa, M. P., Martínez‐Ansó, E., Prìeto, J., & Qian, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0541 · Cited by 138
Epigenetic gene silencing in the Wnt pathway in breast cancer
Klarmann, G. J., Decker, A., & Farrar, W. L. (2008) · Epigenetics · doi:10.4161/epi.3.2.5899 · Cited by 133
Frizzled-7 as a Potential Therapeutic Target in Colorectal Cancer
Ueno, K., Hiura, M., Suehiro, Y., Hazama, S., Hirata, H., Oka, M., Imai, K., Dahiya, R., & Hinoda, Y. (2008) · Neoplasia · doi:10.1593/neo.08320 · Cited by 133
Gazit, A., Yaniv, A., Bafico, A., Tata, P., Igarashi, M., Kitajewski, J., & Aaronson, S. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202985 · Cited by 98
β-Catenin-Independent Wnt Pathways: Signals, Core Proteins, and Effectors
James, R. G., Conrad, W. H., & Moon, R. T. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-249-6_10 · Cited by 80
Wnt-independent activation of β-catenin mediated by a Dkk1-Fz5 fusion protein
Holmen, S. L., Robertson, S., Diegel, C. R., & Williams, B. O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.009 · Cited by 69
Kanzaki, H., Ouchida, M., Hanafusa, H., Yano, M., Suzuki, H., Aoe, M., Imai, K., Shimizu, N., Nakachi, K., & Shimizu, K. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.2.279 · Cited by 51
Verkaar, F., VANROSMALEN, J., Smits, J. F. M., Blankesteijn, W. M., & ZAMAN, G. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.09.008 · Cited by 25
Steinert, G., Oancea, C., Roos, J., Hagemeyer, H., Maier, T. J., Ruthardt, M., & Puccetti, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022540 · Cited by 13
Wnt3‐frizzled 1 chimera as a model to study canonical Wnt signaling
Bhat, R. A., Stauffer, B., Pietra, A. D., & Bodine, P. V. N. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22447 · Cited by 9
Cited by
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Targeting the Wnt/β-catenin signaling pathway in cancer
Zhang, Y., & Wang, X. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00990-3 · Cited by 1,431
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831
“Indeed, multiple attempts to develop antibodies against key Wnt coreceptors, including LRP6 and FZD, have been reported (11, 35, 36) with varying degrees of success.”
BackgroundClara, J. A., Monge, C., Yang, Y., & Takebe, N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752
Metadata
- Authors
- Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., Lam, A., Lazetic, S., Ma, S., Mitra, S., Park, I.-K., Pickell, K., Sato, A., Satyal, S., Stroud, M., Tran, H., Yen, W.-C., Lewicki, J., & Hoey, T.
- Affiliations
- OncoMed (United States) (US)
- OncoMed Pharmaceuticals, Redwood City, CA 94063
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-07-02
- Volume
- 109
- Issue
- 29
- Pages
- 11717-11722
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3406803
- OpenAlex
- W2069750786
- Cited by
- 614
- References
- 44
- Citations by year
- 2026: 16 · 2025: 33 · 2024: 45 · 2023: 51 · 2022: 53 · 2021: 64 · 2020: 57 · 2019: 50 · 2018: 51 · 2017: 49 · 2016: 45 · 2015: 42 · 2014: 32 · 2013: 20 · 2012: 4
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- MorphoSys
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- Wnt/β-catenin signaling, Frizzled receptors, monoclonal antibodies, tumor growth inhibition, tumorigenicity, cancer stem cells, xenografts, chemosensitization, cancer therapy
- MeSH terms
- Animals, Antibodies, Monoclonal, Antineoplastic Agents, Cricetulus, Drug Synergism, Genetic Vectors, Cricetinae, Humans, Immunoglobulin Fab Fragments, Immunohistochemistry, Luciferases, Neoplasms, Blotting, Western, Lentivirus, CHO Cells, Peptide Library, Frizzled Receptors, HEK293 Cells, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.